SignalPath

SignalPath was founded in 2014 by Dr. Brad Hirsch and Kevin Monroe to develop solutions for many of the challenges faced by modern clinical trial management at research sites, with the goal of enabling a technology-supported network of sites to more broadly advance clinical research. The company’s Clinical Trial Management System (CTMS), built by researchers for researchers, aims to significantly enhance the ease, quality, efficiency, and profitability of trial execution.